{"id":"placebo-matched-to-hb-apap","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL470950","moleculeType":"Small molecule","molecularWeight":"460.61"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo formulations are inert preparations designed to match the appearance, taste, and administration route of an active drug to enable blinded clinical trial comparisons. In this Phase 3 trial context, the matched placebo allows assessment of the true efficacy of HB/APAP by controlling for expectancy effects and natural disease progression. The matching ensures that neither patients nor investigators can distinguish the placebo from active treatment based on sensory cues.","oneSentence":"A placebo control matched to the active comparator HB/APAP (hydrocodone bitartrate/acetaminophen) that contains no pharmacologically active ingredients.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:27:51.181Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in Phase 3 clinical trial (indication under investigation for HB/APAP comparator)"}]},"trialDetails":[{"nctId":"NCT05553366","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy","status":"COMPLETED","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2022-10-03","conditions":"Acute Pain","enrollment":1075},{"nctId":"NCT05558410","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of Suzetrigine for Acute Pain After an Abdominoplasty","status":"COMPLETED","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2022-10-10","conditions":"Acute Pain","enrollment":1118},{"nctId":"NCT06619847","phase":"PHASE2","title":"A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy","status":"COMPLETED","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2024-10-29","conditions":"Acute Pain","enrollment":367},{"nctId":"NCT04977336","phase":"PHASE2","title":"A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy","status":"COMPLETED","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2021-07-19","conditions":"Acute Pain","enrollment":274},{"nctId":"NCT05034952","phase":"PHASE2","title":"A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After an Abdominoplasty","status":"COMPLETED","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2021-08-30","conditions":"Acute Pain","enrollment":303},{"nctId":"NCT03206749","phase":"PHASE2","title":"A Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy","status":"COMPLETED","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2017-06-29","conditions":"Acute Pain","enrollment":243}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo (matched to HB/APAP)","genericName":"Placebo (matched to HB/APAP)","companyName":"Vertex Pharmaceuticals Incorporated","companyId":"vertex-pharmaceuticals-incorporated","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo control matched to the active comparator HB/APAP (hydrocodone bitartrate/acetaminophen) that contains no pharmacologically active ingredients. Used for Control arm in Phase 3 clinical trial (indication under investigation for HB/APAP comparator).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}